Novartis AG (XSWX:NOVNEE) FFO


XSWX:NOVNEE Novartis AG XSWX:NOVNEE
83 GF Score
Price CHF119.30
GF Value CHF97.33
! 7 Warning Signs
View Full Analysis

What is Novartis AG FFO?

FFO (Funds from operations) only applies to REITs.

XSWX:NOVNEE
83GF Score
Novartis AG XSWX:NOVNEE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novartis AG (XSWX:NOVNEE) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued. The current stock price of CHF119.30 is trading 22.6% above its estimated GF Value™ of CHF97.33.

Key valuation signals for XSWX:NOVNEE:

  • FFO:
  • GF Value™: CHF97.33 vs. price of CHF119.30 (22.6% above fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the XSWX:NOVNEE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
83GF Score

Get the complete analysis for XSWX:NOVNEE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF119.30
Price
CHF97.33
GF Value